← Back to Clinical Trials
Recruiting NCT06875830

NCT06875830 Comparison of Immediate Implant Placement With Titanium Mesh Versus Collagen Membrane in Type II Socket:

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06875830
Status Recruiting
Phase
Sponsor Misr International University
Condition Bone Augmentation
Study Type INTERVENTIONAL
Enrollment 20 participants
Start Date 2025-03-06
Primary Completion 2026-07-01

Eligibility & Interventions

Sex All sexes
Min Age 21 Years
Max Age 50 Years
Study Type INTERVENTIONAL
Interventions
collagen membranetitanium mesh

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 20 participants in total. It began in 2025-03-06 with a primary completion date of 2026-07-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Statement of the problem: Immediate implant placement is faced with several problems. One of the most important issues is dealing with defects in the buccal plate of bone in the esthetic zone. Aim: The aim of this study is to assess the buccal bone thickness after augmentation with titanium mesh and xenograft upon flapless immediate implant placement.

Eligibility Criteria

Inclusion Criteria: 1. Patients who have at least one remaining root or badly decayed tooth in anterior maxilla. 2. Systemically free patients (American Society of Anesthesiologists I; ASA I) 3. Patients aged from 21 to 50 years old 4. Buccal bone partial deficiency (extraction socket type II) 5. Good oral hygiene 6. Accepts the follow-up period (cooperative patients) 7. Patient accepts to provides an informed consent Exclusion Criteria: 1. Patients with habits that may jeopardize the implant longevity and affect the results of the study such as parafunctional habits such as bruxism 2. Smokers 3. Pregnant and lactating females

Contact & Investigator

Central Contact

Hani El Nahas, PhD

✉ zeinab.hafez@miuegypt.edu.eg

📞 +201221334637

Principal Investigator

ahmed H Farid, Masters

PRINCIPAL INVESTIGATOR

Assistant lecturer

Frequently Asked Questions

Who can join the NCT06875830 clinical trial?

This trial is open to participants of all sexes, aged 21 Years or older, up to 50 Years, studying Bone Augmentation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06875830 currently recruiting?

Yes, NCT06875830 is actively recruiting participants. Contact the research team at zeinab.hafez@miuegypt.edu.eg for enrollment information.

Where is the NCT06875830 trial being conducted?

This trial is being conducted at Cairo, Egypt.

Who is sponsoring the NCT06875830 clinical trial?

NCT06875830 is sponsored by Misr International University. The principal investigator is ahmed H Farid, Masters at Assistant lecturer. The trial plans to enroll 20 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology